Many of Canada’s sophisticated pension funds are at the forefront of a trend to shift asset management functions in-house, and working to navigate their growing requirements for investment operations and systems.
Life sciences investment firm OrbiMed announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million for OrbiMed Asia Partners IV, and $1.2 billion for OrbiMed Royalty & Credit Opportunities III.
Atalaya Capital Management, an alternative asset manager focused on private credit and special opportunities investments, announced the final close of its fifth Asset Income Fund (“AIF V”).